pGEX-2T-Rac1-wt Citations (5)

Originally described in: Bokoch Lab GTPases
Unpublished

---

Articles Citing pGEX-2T-Rac1-wt

Articles
Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington's Disease. Tousley A, Iuliano M, Weisman E, Sapp E, Zhang N, Vodicka P, Alexander J, Aviolat H, Gatune L, Reeves P, Li X, Khvorova A, Ellerby LM, Aronin N, DiFiglia M, Kegel-Gleason KB. J Huntingtons Dis. 2019;8(1):53-69. doi: 10.3233/JHD-180311. PubMed
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization. Bogucka-Janczi K, Harms G, Coissieux MM, Bentires-Alj M, Thiede B, Rajalingam K. Elife. 2023 Apr 14;12:e85167. doi: 10.7554/eLife.85167. PubMed
N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. Koo TY, Lai H, Nomura DK, Chung CY. Nat Commun. 2023 Jun 15;14(1):3564. doi: 10.1038/s41467-023-39268-w. PubMed
A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer. Koo TY, Li JYK, Lee NS, Chen J, Yip HY, Huang IB, Ng KY, Yan HHN, Leung SY, Ma S, Zhou J, Chung CY. Cell Chem Biol. 2025 Sep 18;32(9):1150-1165.e9. doi: 10.1016/j.chembiol.2025.08.004. Epub 2025 Sep 5. PubMed
Protocol to identify covalent inhibitors targeting RhoA Cys16. Koo TY, Ho CS, Yip HY, Chung CY. STAR Protoc. 2026 Jun 19;7(2):104494. doi: 10.1016/j.xpro.2026.104494. Epub 2026 Apr 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.